Search Results - "Kurecic Filipovic, Sanja"
-
1
Epidemiological and clinical features of Croatian children and adolescents with a PCR-confirmed coronavirus disease 2019: differences between the first and second epidemic wave
Published in Croatian medical journal (01-12-2020)“…To describe epidemiological and clinical features of Croatian children and adolescents with a polymerase chain reaction (PCR)-confirmed coronavirus disease…”
Get full text
Journal Article -
2
Measles outbreak in Dubrovnik-Neretva County, Croatia, May to June 2018
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (20-02-2020)“…In May 2018, measles was introduced in the Dubrovnik region by an adult who recently travelled to Kosovo*. Control measures and an outbreak investigation were…”
Get full text
Journal Article -
3
An international outbreak of Salmonella enterica serotype Enteritidis linked to eggs from Poland: a microbiological and epidemiological study
Published in The Lancet infectious diseases (01-07-2019)“…Salmonella spp are a major cause of food-borne outbreaks in Europe. We investigated a large multi-country outbreak of Salmonella enterica serotype Enteritidis…”
Get full text
Journal Article -
4
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024
Published in Vaccine (25-07-2024)“…In autumn 2023, European vaccination campaigns predominantly administered XBB.1.5 vaccine. In a European multicentre study, we estimated 2023 COVID-19 vaccine…”
Get full text
Journal Article -
5
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (26-05-2022)“…IntroductionIn July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe.AimUsing a multicentre test-negative study, we measured COVID-19 vaccine…”
Get full text
Journal Article -
6
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study
Published in Influenza and other respiratory viruses (01-01-2023)“…Background In 2021–2022, influenza A viruses dominated in Europe. The I‐MOVE primary care network conducted a multicentre test‐negative study to measure…”
Get full text
Journal Article -
7
Vaccine effectiveness against influenza A(H3N2) and B among laboratory‐confirmed, hospitalised older adults, Europe, 2017‐18: A season of B lineage mismatched to the trivalent vaccine
Published in Influenza and other respiratory viruses (01-05-2020)“…Background Influenza A(H3N2), A(H1N1)pdm09 and B viruses co‐circulated in Europe in 2017‐18, predominated by influenza B. WHO‐recommended, trivalent vaccine…”
Get full text
Journal Article -
8
An increasing scabies incidence in Croatia: A call for coordinated action among dermatologists, physicians and epidemiologists
Published in Zdravstveno varstvo (01-12-2020)“…The aim of our study was to examine the scabies incidence in the Croatian population and to analyse potential related factors. This mixed ecological study is…”
Get full text
Journal Article -
9
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza
Published in Vaccine (03-08-2017)“…In Europe, annual influenza vaccination is recommended to elderly. From 2011 to 2014 and in 2015–16, we conducted a multicentre test negative case control…”
Get full text
Journal Article -
10
Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
Published in Vaccine: X (10-12-2019)“…•Influenza A(H3N2) circulated in Europe in 2016–17 and 2017–18 and A(H1N1)pdm09 in 2017–18.•Changed A(H1N1)pdm09 vaccine component VE was 58% against…”
Get full text
Journal Article -
11
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (01-03-2018)“…Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines)…”
Get full text
Journal Article -
12
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (21-02-2019)“…Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19…”
Get full text
Journal Article -
13
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (28-11-2019)“…IntroductionInfluenza A(H3N2) clades 3C.2a and 3C.3a co-circulated in Europe in 2018/19. Immunological imprinting by first childhood influenza infection may…”
Get full text
Journal Article -
14
Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data
Published in Vaccine (13-07-2012)“…The YFWG included staff of the US Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), various US academic institutions, the US…”
Get full text
Journal Article -
15
-
16
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022–23 VEBIS multicentre study in Europe
Published in Vaccine (11-06-2024)“…Within influenza vaccine effectiveness (VE) studies at primary care level with a laboratory-confirmed outcome, clinical case definitions for recruitment of…”
Get full text
Journal Article -
17
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
Published in Influenza and other respiratory viruses (01-11-2024)“…ABSTRACT We estimated XBB.1.5 vaccine effectiveness (VE) against symptomatic SARS‐CoV‐2 infection among adults aged ≥ 65 years during the 2023/2024 JN.1…”
Get full text
Journal Article -
18
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project
Published in Euro surveillance : bulletin européen sur les maladies transmissibles (27-07-2017)“…We conducted a multicentre test-negative case-control study in 27 hospitals of 11 European countries to measure 2015/16 influenza vaccine effectiveness (IVE)…”
Get full text
Journal Article -
19
2015/16 I‐MOVE/I‐MOVE+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among children
Published in Influenza and other respiratory viruses (01-07-2018)“…Background During the 2015/16 influenza season in Europe, the cocirculating influenza viruses were A(H1N1)pdm09 and B/Victoria, which was antigenically…”
Get full text
Journal Article -
20
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
Published in JAMA network open (01-07-2024)“…In the context of emerging SARS-CoV-2 variants or lineages and new vaccines, it is key to accurately monitor COVID-19 vaccine effectiveness (CVE) to inform…”
Get full text
Journal Article